Clinical Research Detail Title Of Study Protocol No. ACTG 5175 : Protocol :EVALUATION OF THE EFFICACY OF ANTIRETROVIRAL THERAPY FOR INITIAL TREATMENT OF HIV-1 INFECTED INDIVIDUALS :-ONCE-DAILY PROTEASE INHIBITOR- AND ONCE-DAILY NON-NUCLEOSIDE REVERSE TRAN ASE INHIBITOR-CONTAINING THERAPY COMBINATIONS Disease Condition The primary objective of the study is to demonstrate the non-inferiority of a once-daily PI- and a once-daily NNRTI-containing regimen as compared with standard twice-daily ARV therapy for the initial treatment of individuals infected with HIV-1 from diverse areas of the world. Phase of Trial Phase-4 Discipline Immunology Start date of Trial 5/19/2006 Closing Date of Trial 5/19/2010 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]